Etilaam 1.5 CR Tablet
By Etilaam
Rx
10 Tablet CR in a Strip

Composition
Etizolam(1.5mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
August, 2025

liver
Caution should be exercised when taking Etilaam 1.5 CR Tablet, especially if you have a history of liver diseases or conditions. It is important to consult your doctor before using this medication, as there is limited information available on its use in patients with liver disease. Your doctor may need to adjust the dosage according to your specific situation.

kidney
Limited information is available on the use of Etilaam 1.5 CR Tablet in patients with kidney disease. It is advisable to consult a doctor if you have any concerns regarding the use of this medication in individuals with kidney problems.

alcohol
Consult your doctor when consuming alcohol with Etilaam 1.5 CR Tablet as its safety is unknown. Alcohol may increase drowsiness and other adverse effects when taken with Elm-CR Tablet 10's.

driving
Etilaam 1.5 CR Tablet may cause side effects like sedation and muscle relaxation, which can impair driving ability. Avoid driving if experiencing drowsiness, dizziness, or vision issues after taking Etilaam 1.5 CR Tablet.

pregnancy
The safety of using Etilaam 1.5 CR Tablet during pregnancy is uncertain. It is classified as a Category C pregnancy drug. Please consult your doctor if you are pregnant or planning to become pregnant.

breastfeeding
It is better to consult your doctor before using Etilaam 1.5 CR Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | Thienodiazepines Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Benzodiazepines |
₹141.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025